AartiK.BhatiaMD

Oncology • New Haven, CT

Head & Neck Cancer, Hematologic Oncology

Physician

Join to view full profile

Dr. Bhatia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bhatia's full profile

Already have an account?

Office
333 Cedar St
New Haven, CT 06510
Phone+1 203-785-2360

Fax+1 203-785-4116

Education & Training

Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
Johns Hopkins UniversityResidency, Internal Medicine, 2009 - 2012
Topiwala National Medical CollegeClass of 2007

Certifications & Licensure

CT State Medical License 2015 - 2025
PA State Medical License 2010 - 2015
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck Start of enrollment: 2017 Mar 24
Recruiting
Phase 2
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer Start of enrollment: 2019 Aug 16
Recruiting
Phase 3
Roles: Principal Investigator

Publications & Presentations

PubMed

7 citations
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.
Julie E Bauman, Nabil F Saba, Denise Roe, Jessica R Bauman, John Kaczmar
Journal of Clinical Oncology. 2023-08-01
2 citations
Evaluating the medical management of locally advanced and metastatic basal cell carcinoma: A single institutional retrospective analysis investigating efficacy, safety...
Annika Belzer, Jolanta Pach, Ryland D Mortlock, James Clune, Kelly Olino
JAAD International. 2023-06-01
67 citations
Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update.
Aarti Bhatia, Barbara Burtness
Drugs. 2023-02-01

Journal Articles

Adjuvant Chemotherapy Is Associated with Improved Survival for Late‐Stage Salivary Squamous Cell Carcinoma
Henry S Park, Shayan Cheraghlou, Benjamin L Judson, Aarti Bhatia, Saral Mehra, Amy Schettino, Wendell G Yarbrough, Michael D Otremba, The Laryngoscope

Press Mentions

Emerging Therapies Show Promise in Head and Neck CancerMay 4th, 2017

Professional Memberships

American Society of Clinical Oncology - ASCO
Member